You’re using a public version of DrugPatentWatch with 1 free search available | Register to unlock more free searches. CREATE FREE ACCOUNT

Serving leading biopharmaceutical companies globally:

Last Updated: October 1, 2023

Glenmark Pharms Ltd Company Profile

✉ Email this page to a colleague

« Back to Dashboard

What is the competitive landscape for GLENMARK PHARMS LTD, and what generic and branded alternatives to GLENMARK PHARMS LTD drugs are available?

GLENMARK PHARMS LTD has eighty-two approved drugs.

There are eight tentative approvals on GLENMARK PHARMS LTD drugs.

Summary for Glenmark Pharms Ltd

US Patents:	0
Tradenames:	70
Ingredients:	66
NDAs:	82

Drugs and US Patents for Glenmark Pharms Ltd

+ Get email alerts for changes to this table

Subscribe to access the full database, or Try a Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Glenmark Pharms Ltd	LACOSAMIDE	lacosamide	TABLET;ORAL	205006-003	Mar 17, 2022	AB	RX	No	No		⤷ Try a Trial				⤷ Try a Trial
Glenmark Pharms Ltd	CHLORPROMAZINE HYDROCHLORIDE	chlorpromazine hydrochloride	TABLET;ORAL	212144-004	Mar 23, 2021	AB	RX	No	No		⤷ Try a Trial				⤷ Try a Trial
Glenmark Pharms Ltd	EZETIMIBE AND SIMVASTATIN	ezetimibe; simvastatin	TABLET;ORAL	208699-003	Jun 27, 2019	AB	RX	No	No		⤷ Try a Trial				⤷ Try a Trial
Glenmark Pharms Ltd	NEBIVOLOL HYDROCHLORIDE	nebivolol hydrochloride	TABLET;ORAL	203821-001	May 25, 2017		DISCN	No	No		⤷ Try a Trial				⤷ Try a Trial
Glenmark Pharms Ltd	RUFINAMIDE	rufinamide	TABLET;ORAL	205075-002	May 16, 2016	AB	RX	No	No		⤷ Try a Trial				⤷ Try a Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Similar Applicant Names

Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Moodys

Mallinckrodt

AstraZeneca

McKinsey

Merck

Medtronic

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.